The Asian Leader in IVD and Precision Diagnostics
U-GEN strives to become a leader in the fields of genetic testing, cancer early detection and screening, major chronic diseases and other preventive medicine for Asian and global Chinese population.
Caring of People, Life, and Health
With human life-oriented, U-GEN is a global molecular diagnostic company dedicated to the development, manufacture, sales and marketing of molecular diagnostic kits, instruments, as well as providing the services to end-users directly through reference labs. We integrate the state-of-the-art technology and resources from upstream towards downstream of the IVD industry to develop products for diseases that are the biggest threats to life, especially for the Chinese population.
Genetic Analysis Platform
Expertise in HLA testing kits with the Class III medical device registration certificate of HLA high-resolution testing kit, which is the only one issued by NMPA in China. 
Tumor Early Screening Platform
Multiplex Magnetic Bead Platform
Our Core Competence
U-GEN combines the innovative experience and R&D energy from the United States, China, Hong Kong, and Taiwan, implements semiconductor technology into product development to quickly establish a full range of nucleic acid detection kits and early cancer screening kits for various chronic diseases, provide services for needed people, as well as expanding the market worldwide.
M&A Integration Capacity
Regulatory Capability
Professional Management
Advanced Technology Platforms
U-GEN leverages the most advanced IVD industry technology and methodology in conjunction with our proprietary platforms to develop diagnostic kits, automated equipment, and provide personalized diagnostic services for high-demand markets in China and the world.
Genetic Analysis Platform
Tumor Early Screening Platform
Multiplex Magnetic Bead Platform
3-Early Technologies
U-GEN integrates multiple diagnostic innovations to develop high-value early detection reagents. By analyzing genetic inheritance, epigenetic expression, and acquired mutations, we offers comprehensive solutions for cancer screening and diagnosis.
Early
Assessment
Early
Screening
Early
Diagnosis
News
Group Members
